FDA's Top Drug Regulator Resigns
Digest more
The U.S. Food and Drug Administration announced it will relax certain rules for approving low-cost versions of some ...
A lawsuit filed against George Tidmarsh, who resigned from a top FDA post on Sunday, includes a series of incendiary texts ...
Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...
The Trump administration is proposing changes to Food and Drug Administration guidelines that would make it less expensive ...
The director of the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research, George Tidmarsh, resigned on Sunday amid serious concerns about his personal conduct, a Department of ...
New professional guidance to the nation's pediatricians advises against using a drug in children with autism that many families are clamoring for after it was hyped by federal officials.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback